Target intelligence / Profile preview

Retinal pigment epithelium-retinal G protein-coupled receptor (RGR)

Target
RGR
Molecular classification
G protein-coupled receptor, Opsin family, Retinal photoisomerase subfamily
01

Overview

The Retinal pigment epithelium-retinal G protein-coupled receptor (RGR) is a member of the opsin family, classified among the rhodopsin-like G protein-coupled receptors. Unlike typical signaling GPCRs, RGR-opsin functions primarily as an intracellular photoisomerase, binding all-trans-retinal and catalyzing its conversion to 11-cis-retinal, thus playing an essential role in the visual cycle and regeneration of photopigments[1][2][3]. RGR is mainly expressed in the retinal pigment epithelium (RPE) and Müller glia of the eye, and more recently has been shown to be present in human skin cells such as keratinocytes, melanocytes, and fibroblasts, where it may regulate cell proliferation, migration, and apoptosis[2]. Mutations in the RGR gene have been linked to retinitis pigmentosa and peripapillary choroidal atrophy, supporting its essential role in retinal health[1][2]. Although structurally similar to other opsins, RGR lacks several key GPCR signaling motifs and is not a canonical signaling receptor[2]. No approved drugs specifically target RGR, but its roles in photoreceptor survival and tissue homeostasis suggest its dysfunction can have significant disease consequences[1][2].

Other names
RGR-opsinRP44RPE-retinal G protein-coupled receptorRGR
02

Biological functions

Photoisomerase activity (conversion of all-trans-retinal to 11-cis-retinal)Retinoid cycle/regeneration of rhodopsin and visual pigmentsRegulation of cell proliferation, migration, and apoptosis (notably in skin/keratinocytes)
03

Disease associations

Retinitis pigmentosa (autosomal dominant and autosomal recessive forms)Peripapillary choroidal atrophyOther retinal degenerative diseasesDisease association possible in squamous cell carcinoma and psoriasis based on skin expression
04

Safety considerations

Mutations can lead to photoreceptor degeneration and retinitis pigmentosa[1][2]Overexpression or aberrant splicing can inhibit cellular growth[2]Not considered a druggable GPCR due to lack of canonical signaling motifs[2]
05

Biomarkers

RGR mutations (inherited retinal diseases[1][2])RGR expression (may be elevated in pathological skin conditions, but not established as a therapy biomarker[2])

Beyond the preview

Go deeper on Retinal pigment epithelium-retinal G protein-coupled receptor (RGR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinal pigment epithelium-retinal G protein-coupled receptor (RGR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call